
Opinion|Videos|August 28, 2024
Indolent Metastatic ccRCC Disease Progression and Guideline Updates
Renal cell carcinoma specialists continue analyzing the case of a 61-year-old patient with indolent metastatic clear cell RCC, evaluating available therapeutic options, discussing disease progression, and addressing recent changes in treatment guidelines.
Episodes in this series





































